Carcinoid Syndrome
Pipeline by Development Stage
Drug Modality Breakdown
Competitive Landscape
4 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Clinical Trials (11)
Total enrollment: 904 patients across 11 trials
Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen
Telotristat Etiprate for Carcinoid Syndrome Therapy
Telotristat Etiprate - Expanded Treatment for Patients With Carcinoid Syndrome Symptoms
TELESTAR (Telotristat Etiprate for Somatostatin Analogue Not Adequately Controlled Carcinoid Syndrome)
An Efficacy and Safety Study of Somatuline Depot (Lanreotide) Injection to Treat Carcinoid Syndrome
Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome
Study of Telotristat Etiprate (LX1606) in Participants With Symptomatic Carcinoid Syndrome
Study to Assess the Efficacy and Safety of Different Doses of BIM 23A760 in Patients With Carcinoid Syndrome
Study of Telotristat Etiprate (LX1606) in Participants With Symptomatic Carcinoid Syndrome Not Managed by Stable-Dose Octreotide Therapy
An Open-label Study to Evaluate the Absorption, Metabolism, and Excretion of [14C]-Telotristat Etiprate in Males
Real-world Evidence Study EvaLuating PAtient-Reported Outcomes With XERMELO
Related Jobs
Senior Manager, Clinical Data Management - External Data Management
Associate Director, in Vivo Pharmacology
Vice President, Total Rewards and HR Operations
Associate Director, Outsourcing & Vendor Governance & Supplier Management (CMC)
Manager, Centralized Start Up
Director, Quality Systems, Project Management, QRM, RS
Phase Legend
Key Insights
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.